TrialJournal of Crohn's & colitis2024

Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies.

Bram Verstockt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.